INTRODUCTION
Since the first studies of the use of lithium in manic illnesses by Cade @ and Noack and Trautner (i 955) use of lithium as psychiatric therapy. It was Cade (i@@) who originally pointed out that a satisfactory evaluation of the use of lithium in manic illnesses, although desirable, would be difficult and would probably take several years to complete. The first attempt that was made using â€oe¿ blindâ€• methods was that described by Schou et at. (1954) .
Only two accounts of the use of lithium in psychotic illnesses have been traced to Great Britain. The first was that of Rice (1956) , who described the use of the drug in manic states. Another communication from Hartigan (i 959), however, mentions the value of lithium car bonate in both manic and depressive illnesses.
In order to say that the treatment of mania has been effective it must be possible to deduce that the intensity and/or duration of the indivi dual manic illness has lessened, or that the length of cycle between individual attacks has increased. For the purposes of this investigation the aims were narrowed as follows :â€" (,) To ascertainwhether lithium carbonateis effective in controlling the individual manic illness;
(2) To determine whether there is any cor relation between the biochemical changes and the clinical effect.
It was considered important that this investi gation should be â€oe¿ blindâ€• so that the possible effect of observers' bias would be reduced to a minimum.
The significance of changes in psychiatric states, particularly when dealing with an illness that can remit spontaneously, is always difficult to assess. As Guistino @ pointed out, this is particularly true of mania, and yet Schou in his recent review (i 959) could only instance the attempt of himself and his co-workers as an example of a â€oe¿ blindâ€• type of investigation.
DEFINITION OF MANIA
Mania is taken to mean here an excitability of mood and movement associated with rapid, forceful thinking, in the absence of evidence of incongruity of affect.
All patients had recently developed the acute phase of the illness, the peak of which lay within a period of three months from the time A list of some of the more common toxic and side-effects was given, together with the medicine check list, and the nurse was asked to record each dose of medicine as having been taken and at the same time to indicate on the check list any symptom of toxic or side effect.
During the whole trial it was the aim to take specimens of blood for examination of the electro lytes on two occasions before the commence ment of the trial and thereafter twice weekly. The blood was taken by venous puncture, usually from the antecubital fossa. The tech nical method utilized an EEL flame photometer and is that described by Barrow (5960). Where possible, blood specimens were taken whilst the patient was fasting between 9 a.m. and 10 a.m.
Unfortunately, two patients developed evi dence of lithium toxicity and treatment had to be terminated.
In one of these, high serum levels of lithium preceded the clinical evidence of toxicity and thereafter electrolyte levels were determined at daily intervals in patients receiving either lithium or placebo.
Ideally, the patients were allowed to be fully ambulant and were encouraged to take at least three pints of fluid per day. Full diet with the ordinary amount of table salt usually taken was the rule. Following Schou (@Ã §@)a special daily supplement of salt was not considered necessary.
In the event of toxic or side-effects appearing,
these were recorded and the doctor informed immediately.
The supplied by the nursing staff.
RESULTS
Of the 28 patients (,i male and I 7 female), who were accepted for the trial and commenced treatment, nine did not complete the whole cycle of six weeks' treatment for the following reasons:
two showed toxic effects, t@yo left hospital against medical advice, and five be came so disturbed in behaviour as to be beyond management.
The results from 18 patients only to remember that with lithium levels of less than O5 milli-equivalents per litre the accuracy of the method of assessment is only plus or minus 33 per cent. (Barrow, 1960) . In other words, the two respective peaks could be false ones due to the decreased reliability of the working method at a low level of lithium con centration. Figure 2 , on the other hand, shows the time taken for peak levels of lithium to be reached in whole blood and within the red blood cell. The peak level in whole blood occurred some 24 hours after the cessation of lithium, whilst the level of lithium within the red blood cell went on rising for a further 48 hours before attaining its zenith. These trends suggest that in some As mentioned above, the appearance of severe toxic and side-effects in two of the series of 28 patients resulted in these being withdrawn from the trial. The first patient showed drowsi ness, ataxia, and tremor of the limbs, the other showing all the signs of encephalopathy. Lesser degrees were encountered in both lithium and placebo phases and are described below. The clinical assessor was not, of course, aware of the nature of the medicine being given to the patient, whether placebo or lithium, and it was a question of using clinical judgment and/or the presence of levels in excess of 2 milli-equivalents of lithium per litre as the criterion for the exclusion of such patients from the trial.
Of the patients who completed the clinical trial and whose clinical ratings have been used in the statistical assessment, the side-effects were as follows:
one experienced drowsiness whilst on the drug; one had nausea and vomiting whilst on the placebo. for by chance alone. In discussing the importance of this finding it must be borne in mind that only a very rigid classification of illness was accepted into the trial. Atypical conditions were excluded, as were those patients who suffered from a severe manic excitement (Bell's mania). Likewise, those unable to co operate during a period of six weeks' treatment were rejected. It must also be remembered that this trial was not designed to reveal the effect of lithium upon the long term cyclical nature of the illness. Slater (1938) has observed that certain manic depressives tend to fall ill at particular seasons of the year. The influence of time, too, upon periodic illnesses has been the subject of a study by Crammer (1960) It is possible that â€oe¿ observerenthu siasmâ€• could explain the difference, much along the lines described by Foulds (1958). The results described in this paper are much more in accord with Schou's original findings, for it cannot be claimed that lithium is the panacea for all manic illnesses.
There is much more that needs to be known of the extent and mode of action of lithium salts in manic illnesses. In view of the nature of this psychosis and particularly its tendency to remit and recur spontaneously, a plea must be made for studies in which observer bias can be reduced to a minimum. 
